首页|Correction of a CADASIL point mutation using adenine base editors in hiPSCs and blood vessel organoids

Correction of a CADASIL point mutation using adenine base editors in hiPSCs and blood vessel organoids

扫码查看
Cerebral autosomal dominant arterlopathy with subcortical infarcts and leukoencephalopathy(CADASIL)is a monogenic small vessel disease caused by mutations in the NOTCH3 gene.However,the pathogenesis of CADASIL remains unclear,and patients have limited treatment options.Here,we use human induced pluripotent stem cells(hiPSCs)generated from the peripheral blood mononuclear cells of a patient with CADASIL carrying a heterozygous NOTCH3 mutation(c.1261C>T,p.R421C)to develop a disease model.The correction efficiency of different adenine base editors(ABEs)is tested using the HEK293T-NOTCH3 reporter cell line.ABEmax is selected based on its higher efficiency and minimization of predicted off-target effects.Vascular smooth muscle cells(VSMCs)differentiated from CADASIL hiPSCs show NOTCH3 deposition and abnormal actin cytoskeleton structure,and the abnormalities are recovered in corrected hiPSC-derived VSMCs.Furthermore,CADASIL blood vessel organoids generated for in vivo modeling show altered expression of genes related to disease phenotypes,including the downregulation of cell adhesion,extracellular matrix organization,and vessel development.The dual adeno-associated virus(AAV)split-ABEmax system is applied to the genome editing of vascular organoids with an average editing efficiency of 8.82%.Collectively,we present potential genetic therapeutic strategies for patients with CADASIL using blood vessel organoids and the dual AAV split-ABEmax system.

CADASILInduced pluripotent stem cellsAdenine base editorsAAVBlood vesselOrganoid

Jingwen Wang、Lei Zhang、Guanglan Wu、Jinni Wu、Xinyao Zhou、Xiaolin Chen、Yongxia Niu、Yiren Jiao、Qianyi Liu、Puping Liang、Guang Shi、Xueqing Wu、Junjiu Huang

展开 >

MOE Key Laboratory of Gene Function and Regulation,State Key Laboratory of Biocontrol,School of Life Sciences,Sun Yat-sen University,Guangzhou,Guangdong 510275,China

Key Laboratory of Reproductive Medicine of Guangdong Province,The First Affiliated Hospital and School of Life Sciences,Sun Yat-sen University,Guangzhou,Guangdong 510275,China

Center of Reproductive Medicine,Children's Hospital of Shanxi and Women Health Center of Shanxi,Taiyuan,Shanxi 030013,China

National Natural Science Foundation of ChinaGuangdong Basic and Applied Basic Research FoundationLocal Innovative and Research Teams Project of Guangdong Pearl River Talents Program

319713652020B15151200902019BT02Y276

2024

遗传学报
中国遗传学会 中国科学院遗传与发育生物学研究所

遗传学报

CSTPCD
影响因子:0.821
ISSN:1673-8527
年,卷(期):2024.51(2)
  • 45